Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Don’t waste your time, this company branding and blueprint seem so bright. But the QR can’t prove any growth, and struggle to sustain for revenue. Their product is so so and caused the price of stock sideway all the time. Good luck
My best decision in the past 1 year is cut loss this counters and change to better counter which has more potential. Throughout the year, it proved. Glad that I trust myself, this counters really hard to make it new high.
Hong Leong Investment Bank analyst Chee Kok Siang has initiated coverage on Optimax Holdings with a Buy rating and a target price of RM0.96, implying a 43.3% upside. Chee likes the company for its strong positioning to capitalise on Malaysia’s fast-growing medical eye care industry, and its exposure to upcoming thematic plays in 2026 (Malaysia Year of Medical Tourism) and 2027 (Johor’s next consumption wave).
